Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs

被引：96

作者：

Cuniasse, P

Devel, L

Makaritis, A

Beau, F

Georgiadis, D

Matziari, A

Yiotakis, A

Dive, V ^{[1
]}

机构：

[1] CEA Saclay, Dept Ingn Etudes Prot, F-91191 Gif Sur Yvette, France

[2] Univ Athens, Organ Chem Lab, Dept Organ Chem, Athens 15771, Greece

来源：

BIOCHIMIE | 2005年 / 87卷 / 3-4期

关键词：

MMPs; inhibitors; zinc protease; conformational variability; inhibitor selectivity;

D O I：

10.1016/j.biochi.2004.09.025

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Despite a deep knowledge on the 3D-structure of several catalytic domains of MMPs, the development of highly specific synthetic active-site-directed inhibitors of MMPs, able to differentiate the different members of this protease family, remains a strong challenge. Due to the flexible nature of NIMP active-site, the development of specific NIMP inhibitors will need to combine sophisticated theoretical and experimental approaches to decipher in each MMP the specific structural and dynamic features that can be exploited to obtain the desired selectivity. (c) 2004 Elsevier SAS. All rights reserved.

引用

收藏

页码：393 / 402

页数：10

相关论文

共 69 条

[1] ACE revisited: A new target for structure-based drug design [J].

Acharya, KR ;

Sturrock, ED ;

Riordan, JF ;

Ehlers, MRW .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) :891-902

[2] Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors [J].

Almstead, NG ;

Bradley, RS ;

Pikul, S ;

De, B ;

Natchus, MG ;

Taiwo, YO ;

Gu, F ;

Williams, LE ;

Hynd, BA ;

Janusz, MJ ;

Dunaway, CM ;

Mieling, GE .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) :4547-4562

[3] TNF-α converting enzyme (TACE) is inhibited by TIMP-3 [J].

Amour, A ;

Slocombe, PM ;

Webster, A ;

Butler, M ;

Knight, CG ;

Smith, BJ ;

Stephens, PE ;

Shelley, C ;

Hutton, M ;

Knäuper, V ;

Docherty, AJP ;

Murphy, G .

FEBS LETTERS, 1998, 435 (01) :39-44

[4] Molecular recognition of protein-ligand complexes: Applications to drug design [J].

Babine, RE ;

Bender, SL .

CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472

[5] STROMELYSIN-1 - 3-DIMENSIONAL STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN AND OF THE C-TRUNCATED PROENZYME [J].

BECKER, JW ;

MARCY, AI ;

ROKOSZ, LL ;

AXEL, MG ;

BURBAUM, JJ ;

FITZGERALD, PMD ;

CAMERON, PM ;

ESSER, CK ;

HAGMANN, WK ;

HERMES, JD ;

SPRINGER, JP .

PROTEIN SCIENCE, 1995, 4 (10) :1966-1976

[6] X-ray structures of binary and ternary enzyme-product-Inhibitor complexes of matrix metalloproteinases [J].

Bertini, I ;

Calderone, V ;

Fragai, M ;

Luchinat, C ;

Mangani, S ;

Terni, B .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (23) :2673-2676

[7] 1.8-angstrom crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate prime-side inhibitor with a distinct selectivity profile [J].

Betz, M ;

Huxley, P ;

Davies, SJ ;

Mushtaq, Y ;

Pieper, M ;

Tschesche, H ;

Bode, W ;

GomisRuth, FX .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (01) :356-363

[8] THE X-RAY CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE INHIBITED BY A SUBSTRATE-ANALOG REVEALS THE ESSENTIALS FOR CATALYSIS AND SPECIFICITY [J].

BODE, W ;

REINEMER, P ;

HUBER, R ;

KLEINE, T ;

SCHNIERER, S ;

TSCHESCHE, H .

EMBO JOURNAL, 1994, 13 (06) :1263-1269

[9] STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR [J].

BORKAKOTI, N ;

WINKLER, FK ;

WILLIAMS, DH ;

DARCY, A ;

BROADHURST, MJ ;

BROWN, PA ;

JOHNSON, WH ;

MURRAY, EJ .

NATURE STRUCTURAL BIOLOGY, 1994, 1 (02) :106-110

[10] Structure of recombinant mouse collagenase-3 (MMP-13) [J].

Botos, I ;

Meyer, E ;

Swanson, SM ;

Lemaître, V ;

Eeckhout, Y ;

Meyer, EF .

JOURNAL OF MOLECULAR BIOLOGY, 1999, 292 (04) :837-844

← 1 2 3 4 5 6 7 →